Antibodies to chondroitin sulfate A-binding infected erythrocytes: Dynamics and protection during pregnancy in women receiving intermittent preventive treatment

Journal of Infectious Diseases

Volumn 201, Issue 9, 2010, Pages 1316-1325

  Aitken, Elizabeth H ^a   Mbewe, Bernard ^c   Luntamo, Mari ^d   Maleta, Ken ^c   Kulmala, Teija ^d   Friso, Marc James ^a   Fowkes, Freya J I ^b   Beeson, James G ^b   Ashorn, Per ^d,e   Rogerson, Stephen J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF MALAWI   (Malawi)

^d UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^e TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CHONDROITIN 4 SULFATE; HEMOGLOBIN; IMMUNOGLOBULIN G; ANTIMALARIAL AGENT; CHONDROITIN SULFATE; FANSIDAR; MEMBRANE ANTIGEN; PROTOZOON ANTIBODY; PYRIMETHAMINE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG INTERMITTENT THERAPY; ERYTHROCYTE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALAWI; PLASMODIUM FALCIPARUM; PREGNANCY; PRIORITY JOURNAL; BLOOD; DRUG COMBINATION; IMMUNOLOGY; LONGITUDINAL STUDY; MALARIA FALCIPARUM; METABOLISM; PARASITOLOGY; PARITY; PREGNANCY COMPLICATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIBODIES, PROTOZOAN; ANTIGENS, SURFACE; ANTIMALARIALS; CHONDROITIN SULFATES; DRUG COMBINATIONS; ERYTHROCYTES; FEMALE; HUMANS; IMMUNOGLOBULIN G; LONGITUDINAL STUDIES; MALARIA, FALCIPARUM; MALAWI; PARITY; PLASMODIUM FALCIPARUM; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PYRIMETHAMINE; SULFADOXINE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77950955741     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/651578     Document Type: Article

References (37)

1. Desai M, Ter Kuile FO, Francois N, et al. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis 2007; 7:93-104.
2. Fried M, Duffy PE. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 1996; 272:1502-1504
3. Beeson JG, Brown GV, Molyneux ME, Mhango C, Dzinjalamala F, Rogerson SJ. Plasmodium falciparum isolates from infected pregnant women and children are associated with distinct adhesive and antigenic properties. J Infect Dis 1999;180:464-472
4. Salanti A, Dahlb̃ck M, Turner L, et al. Evidence for the involvement of'VAR2CSA in pregnancy-associated malaria. J Exp Med 2004;200: 1197-1203 (Pubitemid 39507059)
5. Ricke CH, Staalsoe T, Koram K, et al. Plasma antibodies from malariaexposed pregnant women recognize variant surface antigens on Plasmodium falciparum-iniected erythrocytes in a parity-dependent manner and block parasite adhesion to chondroitin sulfate A. J Immunol 2000;165:3309-3316
6. Rogerson SJ, Hviid L, Duffy PE, Leke R, Taylor DW. Malaria in pregnancy: pathogenesis and immunity. Lancet 2007;7:105-117
7. Staalsoe T, Shulman CE, Bulmer JN, Kawuondo K, Marsh K, Hviid L. Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria. Lancet 2004;363:283-289
8. Duffy PE, Fried M. Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with increased birth weight and the gestational age of newborns. Infect Immun 2003; 71: 6620-6623
9. Menendez C, D'Alessandro U, Ter Kuile FO. Reducing the burden of malaria in pregnancy by preventive strategies. Lancet Infect Dis 2007;7: 126-135 (Pubitemid 46137946)
10. Staalsoe T, Shulman CE, Dorman EK, Kawuondo K, Marsh K, Hviid L. Intermittent preventive sulfadoxine-pyrimethamine treatment of Primigravidae reduces levels of plasma immunoglobulin G, which protects against pregnancy-associated Plasmodium falciparum malaria. Infect Immun 2004; 72:5027-5030 (Pubitemid 39223386)
11. Rogerson SJ, Chiayaroj SC, Ng K, Reeder JC, Brown GV. Chondroitin sulfate A is a cell surface receptor for Plasmodium falciparum-infected erythrocytes. J Exp Med 1995; 182:15-20.
12. Beeson JG, Brown GV. Plasmodium falciparum-infected erythrocytes demonstrate dual specificity for adhesion to hyaluronic acid and chondroitin sulfate A and have distinct adhesive properties. J Infect Dis 2004;189:169-179
13. Duffy MF, Byrne TJ, Elliott SR, et al. Broad analysis reveals a consistent pattern of var gene transcription in Plasmodium falciparum repeatedly selected for a defined adhesion phenotype. Mol Microbiol 2005; 56:774-788
14. Elliott SR, Duffy MF, Byrne TJ, et al. Cross-reactive surface epitopes on chondroitin sulfate A-adherent Plasmodium falciparum-infected erythrocytes are associated with transcription of varlcsa. Infect Immun 2005;73:2848-2856
15. Beeson JG, Mann EJ, Elliott SR, et al. Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes and adhesion inhibitory antibodies are associated with placental malaria and have overlapping and distinct targets. J Infect Dis 2004;189:540-551
16. Mount AM, Mwapasa V, Elliott SR, et al. Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection. Lancet 2004;363:1860-1867
17. Persson KE, McCallum FJ, Reiling L, et al. Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies. J Clin Invest 2008;118:342-351
18. World Health Organization (WHO). A strategic framework for malaria prevention and control during pregnancy in the African region. Brazzaville: WHO Regional Office for Africa, 2004. WHO reference number AFR/MAL/04/01.
19. Fried M, Nosten F, Brockman A, Brabin B, Duffy PE. Maternal antibodies block malaria. Nature 1998;395:851-852
20. Staalsoe T, Megnekou R, Fievét N, et al. Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum infected erythrocytes that protect against placental parasitemia. J Infect Dis 2001;184:618-626
21. Beeson JG, Mann EJ, Byrne TJ, et al. Antigenic differences and conservation among placental Plasmodium falciparum-infected erythrocytes and acquisition of variant-specific and cross-reactive antibodies. J Infect Dis 2006; 193:721-730
22. Jauniaux E, Hempstock J, Greenwold N, Burton GJ. Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. Am J Pathol 2003; 162:115-125 (Pubitemid 36041994)
23. Cox SE, Staalsoe T, Arthur P, et al. Rapid acquisition of isolate-specific antibodies to chondroitin sulfate A-adherent Plasmodium falciparum isolates in Ghanian Primigravidae. Infect Immun 2005; 73:2841-2847
24. Kinyanjui SM, Bull P, Newbold CI, Marsh K. Kinetics of antibody responses to Plasmodium falciparum-infected erythrocyte variant surface antigens. J Infect Dis 2003;187:667-674
25. Nosten F, McGready R, Simpson JA, et al. Effects of Plasmodium vivax malaria in pregnancy. Lancet 1999;354:546-549
26. Rogerson SJ, Mkundika P, Kanjala MK. Diagnosis of Plasmodium falciparum malaria at delivery: a comparison of blood film preparation methods, and of blood films with histology. J Clin Microbiol 2003; 41: 1370-1374
27. Sutherland CJ, Drakeley CJ, Schellenberg D. How is childhood development of immunity to Plasmodium falciparum enhanced by certain antimalarial interventions? Malar J 2007;6:161.
28. Greenwood AM, Menendez C, Alonso PL, et al. Can malaria chemoprophylaxis be restricted to first pregnancies? Trans R Soc Trop Med Hyg 1994;88:681-682
29. Keen J, Serghides L, Ayi K, et al. HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites. PLoS Med 2007; 4:912-920 (Pubitemid 46842581)
30. Feng G, Aitken E, Yosaatmadja F, et al. Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes are associated with protection from treatment failure and the development of anemia in pregnancy. J Infect Dis 2009; 200:299-306.
31. Ceesay SJ, Casals-Pascual C, Erskine J, et al. Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis. Lancet 2008;372:1545-1554
32. O'Meara WP, Bejon P, Mwangi TW, et al. Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya. Lancet 2008;372:1555-1562
33. Steketee RW, Wirima JJ, Bioland P, et al. Impairment of a pregnant woman's acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1. Am J Trop Med Hyg 1996; 55:42-49
34. Verhoeff F, Brabin B, Chimsuku P, Kazembe P, Broadhead R. Malaria in pregnancy and its consequences for the infant in rural Malawi. Ann Trop Med Parasitol 1999; 93:S25-S33.
35. Kulmala T, Vaahtera M, Ndekha M, et al. The importance of preterm births for peri- and neonatal mortality in rural Malawi. Paediatr Perinat Epidemiol 2000; 14:219-226 (Pubitemid 30599069)
36. Rogerson SJ, Chaluluka E, Kanjala M, Mkundika P, Mhango C, Molyneux ME. Intermittent sulfadoxine-pyrimethamine in pregnancy: effectiveness against malaria morbidity in Blantyre, Malawi, in 1997-1999. Trans R Soc Trop Med Hyg 2000;94:549-553
37. Cottrell G, Briand V, Cot M. Interest and limits of cohort studies in pregnant women. Lancet Infect Dis 2007; 7:763-764 (Pubitemid 350152039)